VOICED : Perú suspende por precaución el ensayo de vacuna china contra el covid-19

The Peruvian Ministry of Health temporarily suspended Chinese COVID-19 vaccine trials after a participant showed symptoms potentially linked to Guillain-Barré syndrome. The trials, conducted by two Peruvian universities, aimed to test the vaccine on 12,000 volunteers. Despite the low probability of a direct link, the suspension was a precautionary measure. If successful, Peru planned to purchase 20 million doses to vaccinate two-thirds of its population.

Why did the Peruvian Ministry of Health decide to suspend the vaccine trials?

• Due to a lack of funding

• Because of a serious adverse event in a participant

• The vaccine was found ineffective

• The trials were completed successfully

What symptoms were observed in the participant that led to the suspension of the trials?

• Neurological symptoms

• Severe allergic reaction

• Respiratory issues

• Cardiac arrest

What syndrome was suspected in the participant showing adverse symptoms?

• Guillain-Barré syndrome

• Down syndrome

• Asperger syndrome

• Tourette syndrome

Who was responsible for conducting the vaccine trials in Peru?

• The World Health Organization

• The Peruvian government

• Two Peruvian universities

• A private pharmaceutical company

What was the Peruvian government's plan if the vaccine trials showed positive results?

• To conduct trials in other countries

• To develop a new vaccine

• To purchase 20 million vaccines

• To halt all further trials